P&G Gains Ground but Commodity Costs Loom Over the Bull Case

Procter & Gamble has added 1.8% on the week to $162.06, the stock's best weekly gain since the post-earnings bounce, but the debate is now shifting from momentum to margin.

Options positioning has quietly turned less bullish than the recent run might suggest. The put/call ratio edged back up to 0.627 on Tuesday, a touch above where it finished last week at 0.621, and roughly 1.1 standard deviations below its 20-day mean of 0.688. That is still call-heavy by the standards of the past year, whose high was 1.11, but the drift back toward the mean is worth noting after the near-extreme readings of late October. Borrow conditions remain completely immaterial to the investment case: short interest is 0.93% of the free float, up fractionally on the week but down 12% over the past month, and availability is so deep that there is essentially no short-side friction. Cost to borrow at 0.37% is similarly trivial.

The Street remains broadly constructive, though the consensus has settled rather than extended. The mean price target is $174, implying around 7% upside from the current price. The bulk of that target activity came in one burst after the October 22 earnings print, when JP Morgan raised to $180, UBS to $190, Citigroup to $187, and BNP Paribas to $189. Barclays and Piper Sandler followed on October 26 with more modest lifts, to $165 and $167 respectively, both maintaining neutral-equivalent ratings. The analyst recommendation factor scores in the 94th percentile, the strongest single reading across P&G's factor profile. The dividend factor scores in the 98th percentile. Where the picture softens is on earnings momentum: the 30-day and 90-day EPS momentum scores are in the 38th and 34th percentiles, below mid-table, and the EV/EBITDA multiple at 15.7x has drifted lower over the past month. The PE of 22x is up around 2 points over 30 days, reflecting the stock's re-rating more than any change in the earnings estimate.

The bull and bear cases are now squarely focused on costs. Bulls point to Q1 organic sales growth of 4% against a 2.2% consensus, volume adding 2.4 percentage points, and share stability or gains in 29 of 50 country and category combinations, including resilience in China and Europe. Bears counter that management has already raised commodity inflation guidance to $1.4 billion after-tax, roughly 4% of cost of goods sold, and that oil above $110 per barrel keeps the pressure alive. Pricing power is thin: only 0.4% pricing came through in Q1 in what management called a fierce promotional environment. Gross margin fell 152 basis points in the quarter and an additional 200 basis point decline is flagged for Q2. That is the tension the stock is now priced around.

Insider activity over the past two weeks adds colour but not a strong directional signal. The CEO, Shailesh Jejurikar, exercised options and sold 35,000 shares at $163 on October 23, netting roughly $5.7 million. The head of the Fabric, Home and Habitat Care division sold 38,253 shares the following week at $165. The Chief Research and Innovation Officer did the same with 18,812 shares. All three were paired exercise-and-sell transactions rather than open-market discretionary sales, reducing their informational weight. No open-market purchases appear in the recent filings. The 90-day net across all insiders is a sale of about $20 million, modest relative to the company's scale. Among peers this week, CLX stood out with a 4.3% single-day gain, while KMB dropped 3.5% on the day and is down 4.3% on the week, the weakest move in the peer group.

The next focal point for P&G is whether Q2 results, when they arrive, bear out the gross margin warning management already delivered, or whether commodity costs ease enough to narrow the gap between the current price and a consensus target that is now almost fully priced in analyst optimism from the Q1 beat.